2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
2019 · European Heart Journal · 8,581 citations
https://doi.org/10.1093/eurheartj/ehz455
K
Kausik K. Ray
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
836
Papers
86.9K
Citations
120
h-index
378
i10-index
Kausik K. Ray is an academic researcher from United Nations Industrial Development Organization. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Health Systems, Economic Evaluations, Quality of Life & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 120, co-authored 711 publications.
ORCID: 0000-0003-0508-0954Papers by this author
works2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
2021 · European Heart Journal · 5,787 citations
https://doi.org/10.1093/eurheartj/ehab484
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2020 · European Heart Journal · 4,917 citations
https://doi.org/10.1093/eurheartj/ehaa575
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
2017 · European Heart Journal · 3,678 citations
https://doi.org/10.1093/eurheartj/ehx144
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 · New England Journal of Medicine · 3,421 citations
https://doi.org/10.1056/nejmoa1307684
Lipoprotein(a) as a cardiovascular risk factor: current status
2010 · European Heart Journal · 1,758 citations
https://doi.org/10.1093/eurheartj/ehq386
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat